We are live on ! Find out more
AAMU

Amundi Asset Management US Portfolio holdings

AUM $131B
1-Year Est. Return 73.57%
This Fund
S&P 500
This Quarter Est. Return
+7.37%
1 Year Est. Return
+73.57%
3 Year Est. Return
+96.88%
5 Year Est. Return
+179.37%
10 Year Est. Return
AUM
$131B
AUM Growth
+$13.2B
Cap. Flow
+$5.89B
Cap. Flow %
4.5%
Top 10 Hldgs %
19.25%
Holding
1,602
New
125
Increased
675
Reduced
530
Closed
75

Top Buys

Rank Stock Value
1
STLA icon
Stellantis
STLA
+$835M
2
MSFT icon
Microsoft
MSFT
+$367M
3
SLB icon
SLB Ltd
SLB
+$359M
4
NVDA icon
NVIDIA
NVDA
+$334M
5
DHR icon
Danaher
DHR
+$325M

Sector Composition

Rank Sector Weight
1 Technology 22.51%
2 Consumer Discretionary 14.79%
3 Healthcare 13.45%
4 Financials 12.71%
5 Industrials 9.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WY icon
1301
CALL
Weyerhaeuser
WY
$17B
$356K ﹤0.01%
10,000
CIGI icon
1302
Colliers International
CIGI
$5.26B
$354K ﹤0.01%
3,600
+1,500
+71% +$147K
CROX icon
1303
Crocs
CROX
$5.86B
$353K ﹤0.01%
4,390
-2,110
-32% -$161K
GBCI icon
1304
Glacier Bancorp
GBCI
$6.1B
$352K ﹤0.01%
6,172
-3,028
-33% -$164K
UPWK icon
1305
Upwork
UPWK
$1.13B
$352K ﹤0.01%
+7,866
New +$363K
ALX
1306
Alexander's
ALX
$1.38B
$351K ﹤0.01%
1,266
OZK icon
1307
Bank OZK
OZK
$5.39B
$348K ﹤0.01%
8,524
-3,976
-32% -$157K
IRTC icon
1308
iRhythm Holdings
IRTC
$3.96B
$347K ﹤0.01%
2,500
EVLO
1309
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$347K ﹤0.01%
+1,624
New +$449K
AGIO icon
1310
Agios Pharmaceuticals
AGIO
$1.99B
$346K ﹤0.01%
6,700
ALLK
1311
DELISTED
Allakos
ALLK
$344K ﹤0.01%
3,000
MRCY icon
1312
Mercury Systems
MRCY
$5.32B
$342K ﹤0.01%
4,846
-4,326
-47% -$313K
TWST icon
1313
Twist Bioscience
TWST
$8.87B
$341K ﹤0.01%
2,753
-1,247
-31% -$189K
ONEM
1314
DELISTED
1Life Healthcare
ONEM
$340K ﹤0.01%
8,700
LIVN icon
1315
LivaNova
LIVN
$4.43B
$339K ﹤0.01%
+4,600
New +$328K
PPC icon
1316
Pilgrim's Pride
PPC
$7.55B
$336K ﹤0.01%
14,118
-11,701
-45% -$259K
FIZZ icon
1317
National Beverage
FIZZ
$3.05B
$335K ﹤0.01%
6,851
-2,149
-24% -$112K
NFE icon
1318
New Fortress Energy
NFE
$83.6M
$335K ﹤0.01%
+7,300
New +$357K
ARNA
1319
DELISTED
Arena Pharmaceuticals Inc
ARNA
$333K ﹤0.01%
4,800
VIR icon
1320
Vir Biotechnology
VIR
$1.83B
$332K ﹤0.01%
6,475
-10,536
-62% -$568K
AMBA icon
1321
Ambarella
AMBA
$3.1B
$331K ﹤0.01%
+3,300
New +$359K
LPSN icon
1322
LivePerson
LPSN
$34.8M
$331K ﹤0.01%
419
-80
-16% -$74.1K
SPSC icon
1323
SPS Commerce
SPSC
$3.06B
$330K ﹤0.01%
3,324
-2,200
-40% -$232K
ACHC icon
1324
Acadia Healthcare
ACHC
$2.66B
$329K ﹤0.01%
5,751
-2,849
-33% -$154K
HOMB icon
1325
Home BancShares
HOMB
$5.93B
$329K ﹤0.01%
12,152
-3,848
-24% -$92.5K

Similar funds

Amundi Asset Management US's Q1 2021 Portfolio in Review

As of Q1 2021, Amundi Asset Management US held 1,602 positions worth $131B, up 11% from $118B the previous quarter. Its ten largest holdings account for 19% of the portfolio.

Amundi Asset Management US deployed $5.89B of net new capital in Q1 2021, opening 125 new positions and adding to 675 existing holdings. Its largest new stake was New Oriental: 900,958 shares worth $126M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 24% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Bank of America, an estimated $332M trimmed.

  • Amundi Asset Management US's largest Q1 2021 buy was New Oriental: 900,958 shares worth $126M.
  • Amundi Asset Management US added most to Stellantis in Q1 2021, an estimated $835M increase.
  • Amundi Asset Management US's biggest Q1 2021 reduction was Bank of America, cutting an estimated $332M.
  • Amundi Asset Management US fully exited Marvell Technology in Q1 2021, selling an estimated $246M.
  • Amundi Asset Management US's ten largest holdings make up 19% of its $131B portfolio in Q1 2021.
  • Amundi Asset Management US opened 125 new positions and closed 75 in Q1 2021.
  • Amundi Asset Management US's portfolio value rose 11% quarter-over-quarter to $131B.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.